Detalles de la búsqueda
1.
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails.
Blood
; 135(16): 1386-1395, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932846
2.
Time-dependent prediction of mortality and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation using machine learning.
Am J Hematol
; 97(10): 1309-1323, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071578
3.
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies.
Am J Transplant
; 20(3): 677-688, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31597002
4.
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 24(12): 2558-2567, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29966760
5.
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.
Br J Haematol
; 180(6): 840-853, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29468631
6.
Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.
Blood
; 128(1): 120-9, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27162243
7.
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.
Br J Haematol
; 175(1): 115-22, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27341180
8.
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.
Blood
; 118(5): 1402-12, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21540462
9.
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood
; 117(23): 6375-82, 2011 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21467544
10.
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Biol Blood Marrow Transplant
; 18(11): 1716-26, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22713691
11.
Nodal follicular lymphoma: the role of radiotherapy for stages I and II.
Strahlenther Onkol
; 186(4): 191-6, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354662
12.
Advanced-stage III/IV follicular lymphoma: treatment strategies for individual patients.
Strahlenther Onkol
; 186(5): 247-54, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20437015
13.
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol
; 10(9): 855-64, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19695955
14.
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Ann Hematol
; 88(12): 1237-47, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19319532
15.
Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Int J Radiat Oncol Biol Phys
; 70(2): 523-8, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17869449
16.
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
J Clin Virol
; 99-100: 61-66, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331844
17.
Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.
J Cancer Res Clin Oncol
; 144(6): 1173-1183, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29623467
18.
No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors.
Blood
; 115(17): 3644-5; author reply 3645-6, 2010 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-20430969
19.
Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
Exp Hematol
; 34(12): 1753-8, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17157173
20.
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.
Lancet Haematol
; 4(6): e293-e301, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28583289